The TRITON versus PLATO trials: Differences beyond platelet inhibitionSEREBRUANY, Victor L.Thrombosis and haemostasis. 2010, Vol 103, Num 2, pp 259-261, issn 0340-6245, 3 p.Article

Aggressive chronic platelet inhibition with prasugrel and increased cancer risks: revising oral antiplatelet regimens?SEREBRUANY, Victor L.Fundamental & clinical pharmacology. 2009, Vol 23, Num 4, pp 411-417, issn 0767-3981, 7 p.Article

Adenosine release: A potential explanation for the benefits of ticagrelor in the PLATelet Inhibition and Clinical Outcomes trial?SEREBRUANY, Victor L.The American heart journal. 2011, Vol 161, Num 1, pp 1-4, issn 0002-8703, 4 p.Article

Selective serotonin reuptake inhibitors and increased bleeding risk : Are we missing something?SEREBRUANY, Victor L.The American journal of medicine. 2006, Vol 119, Num 2, pp 113-116, issn 0002-9343, 4 p.Article

Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verifiedSEREBRUANY, Victor L.Thrombosis and haemostasis. 2011, Vol 105, Num 5, pp 752-759, issn 0340-6245, 8 p.Article

The PLATO trial: do you believe in magic?SEREBRUANY, Victor L; ATAR, Dan.European heart journal. 2010, Vol 31, Num 7, pp 764-767, issn 0195-668X, 4 p.Article

Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials ― Common patterns in TRITON, RECORD, and PLATO?SEREBRUANY, Victor L; ATAR, Dan.Thrombosis and haemostasis. 2012, Vol 108, Num 3, pp 412-414, issn 0340-6245, 3 p.Article

Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With DiabetesDINICOLANTONIO, James J; SEREBRUANY, Victor L.Diabetes (New York, NY). 2013, Vol 62, Num 3, pp 669-671, issn 0012-1797, 3 p.Article

Viewpoint: Mismatch between the European and American guidelines on oral antiplatelet P2Y₁₂ inhibitors after acute coronary syndromesSEREBRUANY, Victor L; DINICOLANTONIO, James J.Thrombosis and haemostasis. 2013, Vol 110, Num 1, pp 5-10, issn 0340-6245, 6 p.Article

Comparing Ticagrelor Versus Clopidogrel in Patients With a History of Cerebrovascular Disease: A Net Clinical Harm?DINICOLANTONIO, James J; SEREBRUANY, Victor L.Stroke (1970). 2012, Vol 43, Num 12, pp 3409-3410, issn 0039-2499, 2 p.Article

Viewpoint: Underutilisation of novel antiplatelet agents - myths, generics, and economicsSEREBRUANY, Victor L; FORTMANN, Seith D.Thrombosis and haemostasis. 2014, Vol 112, Num 1, pp 4-9, issn 0340-6245, 6 p.Article

Prasugrel as a Potential Cancer Promoter: Review of the Unpublished DataFLOYD, James S; SEREBRUANY, Victor L.Archives of internal medicine (1960). 2010, Vol 170, Num 12, pp 1078-1080, issn 0003-9926, 3 p.Article

Oral platelet IIb/IIIa inhibitors : From attractive theory to clinical failuresGURBEL, Paul A; SEREBRUANY, Victor L.Journal of thrombosis and thrombolysis. 2000, Vol 10, Num 3, pp 217-220, issn 0929-5305Article

Impact of clopidogrel and potent P2Y₁₂-inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A systematic review and meta-analysisARADI, Dániel; KOMOCSI, András; VOROBCSUK, András et al.Thrombosis and haemostasis. 2013, Vol 109, Num 1, pp 93-101, issn 0340-6245, 9 p.Article

Cangrelor infusion is associated with an increased risk for bleeding: Meta-analysis of randomized trialsSEREBRUANY, Victor L; ARADI, Daniel; MOO HYUN KIM et al.International journal of cardiology. 2013, Vol 169, Num 3, pp 225-228, issn 0167-5273, 4 p.Article

Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers : The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan)SEREBRUANY, Victor L; MALININ, Alex I; HANLEY, Dan F et al.Thrombosis and haemostasis. 2008, Vol 99, Num 1, pp 116-120, issn 0340-6245, 5 p.Article

Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrelARADI, Dániel; KULICZKOWSKI, Wiktor; ATAR, Dan et al.Thrombosis and haemostasis. 2012, Vol 107, Num 2, pp 338-345, issn 0340-6245, 8 p.Article

Rapid platelet inhibition after a single capsule of Aggrenox®: Challenging a conventional full-dose aspirin antiplatelet advantage?SEREBRUANY, Victor L; MALININ, Alex I; SANE, David C et al.American journal of hematology. 2003, Vol 72, Num 4, pp 280-281, issn 0361-8609, 2 p.Article

Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirinMALININ, Alex I; CALLAHAN, Kevin P; SEREBRUANY, Victor L et al.Thrombosis research. 2001, Vol 104, Num 4, pp 297-299, issn 0049-3848Article

Antiplatelet 'resistance' and 'non-responders' : what do these terms really mean?SEREBRUANY, Victor L; EISERT, Christian; ATAR, Dan et al.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 11-18, issn 0767-3981, 8 p.Article

Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery diseaseSEREBRUANY, Victor L; O'CONNOR, Christopher M; GURBEL, Paul A et al.The American journal of cardiology. 2001, Vol 87, Num 12, pp 1398-1400, issn 0002-9149Article

Soluble P-selectin is not a surrogate marker for platelet p-selectin : Evidence from a multicenter chest pain study groupGURBEL, Paul A; KEREIAKES, Dean J; SEREBRUANY, Victor L et al.Journal of thrombosis and thrombolysis. 2000, Vol 10, Num 1, pp 15-22, issn 0929-5305Article

Disbalance between mortality and non-fatal vascular events in the CHAMPION-PHOENIX trial: The cangrelor efficacy challengeSEREBRUANY, Victor L; POKOV, Alex N; FORTMANN, Seth D et al.Thrombosis and haemostasis. 2014, Vol 111, Num 1, pp 3-7, issn 0340-6245, 5 p.Article

Antiplatelet Profiles of the Fixed-Dose Combination of Extended-Release Dipyridamole and Low-Dose Aspirin Compared with Clopidogrel With or Without Aspirin in Patients with Type 2 Diabetes and a History of Transient Ischemic Attack : A Randomized, Single-Blind, 30-Day TrialSEREBRUANY, Victor L; MALININ, Alex I; POKOV, Alex N et al.Clinical therapeutics. 2008, Vol 30, Num 2, pp 249-259, issn 0149-2918, 11 p.Article

Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapyGURBEL, Paul A; O'CONNOR, Christopher M; DALESANDRO, Margaret R et al.The American journal of cardiology. 2001, Vol 87, Num 6, pp 774-777, issn 0002-9149Article